Cellulite Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Procedure Type (Non-invasive treatment, Minimally invasive treatment, Topical treatment), By Cellulite Type (Soft cellulite, Hard cellulite, Edematous cellulite), By End-use (Hospitals, Clinics & beauty Centers, Others) Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 1.61 Billion
CAGR (2026-2031)	7.89%
Fastest Growing Segment	Non-Invasive Treatment
Largest Market	North America
Market Size (2031)	USD 2.54 Billion

Market Overview

The Global Cellulite Treatment Market will grow from USD 1.61 Billion in 2025 to USD 2.54 Billion by 2031 at a 7.89% CAGR. Cellulite treatment encompasses non-invasive and minimally invasive aesthetic procedures designed to diminish the dimpled appearance of skin caused by subcutaneous fat deposits, predominantly on the thighs and buttocks. The primary drivers propelling market growth include the rising global prevalence of obesity and an aging population, which naturally exacerbate skin laxity and cellulite formation. Additionally, heightened consumer awareness regarding body contouring and the preference for clinical interventions requiring minimal recovery time effectively support industry demand. According to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2023, 331,981 cellulite treatment procedures were performed globally.

However, a significant challenge impeding broader market expansion is the high cost associated with these elective procedures combined with the absence of medical reimbursement. As cellulite reduction is categorized as a cosmetic intervention, patients are required to cover the entire expense out-of-pocket, which restricts market penetration among price-sensitive consumer segments. Furthermore, the frequent necessity for multiple treatment sessions to achieve and maintain visible results can deter potential clients, thereby limiting the potential customer base.

Key Market Drivers

Surging consumer demand for non-invasive and minimally invasive procedures is a primary catalyst expanding the Global Cellulite Treatment Market. Patients increasingly prioritize aesthetic interventions that offer effective results with reduced recovery times and lower risks compared to traditional surgical options. This shift is particularly relevant for cellulite reduction, where energy-based devices and injectables are becoming the preferred modalities over invasive surgery. The growing patient preference for these "lunchtime procedures" has significantly boosted the volume of treatments performed. According to the American Society of Plastic Surgeons, June 2025, in the '2024 Procedural Statistics Report', the total number of minimally invasive cosmetic procedures performed reached over 28.5 million in 2024. This robust volume underscores the critical role of non-surgical options in driving industry turnover.

Increasing global disposable income and spending on aesthetic care also play a pivotal role in propelling market growth. As economic conditions stabilize and personal wealth rises, consumers are more willing to invest in elective cosmetic treatments to improve their body image and self-confidence. This financial capacity allows a broader demographic to access premium aesthetic services, including advanced cellulite reduction therapies. According to Galderma, March 2025, in the 'Full Year 2024 Results' announcement, the company reported record net sales of $4.4 billion for the full year 2024, reflecting the sustained financial momentum within the broader aesthetic sector. Additionally, the market is supported by the continued relevance of surgical interventions; according to the International Society of Aesthetic Plastic Surgery, in 2025, it was reported that 17.4 million surgical procedures were performed worldwide in 2024.

Download Free Sample Report

Key Market Challenges

The high cost associated with elective procedures, combined with the complete absence of medical reimbursement, stands as the primary obstacle impeding the growth of the Global Cellulite Treatment Market. Because cellulite reduction is classified strictly as a cosmetic enhancement rather than a medical necessity, insurance providers do not cover the expenses, forcing patients to bear the full financial burden out-of-pocket. This financial barrier effectively excludes a large demographic of price-sensitive consumers who might otherwise seek treatment. The economic strain is further compounded by the clinical requirement for multiple sessions to achieve perceptible results, which significantly escalates the total investment for the patient.

Consequently, this high cost-of-entry directly dampens procedure volumes and market expansion. Potential clients are often deterred by the recurring expense required to maintain outcomes, leading to lower patient retention and acquisition rates. This trend of reduced engagement in body-focused interventions is evident in recent industry data. According to the International Society of Aesthetic Plastic Surgery (ISAPS), in 2024, the total number of body and extremities procedures performed globally decreased by 14.8% compared to the previous year, highlighting a distinct shift in consumer spending away from these high-cost body treatments.

Key Market Trends

The market is witnessing a decisive shift toward acoustic wave and radiofrequency technologies, driven by their ability to target subcutaneous fat and stimulate collagen production. These energy-based devices offer consistent outcomes, fostering a business model reliant on recurring consumable usage rather than solely capital equipment sales. This technological evolution enables practitioners to treat cellulite at multiple depths, significantly improving patient retention. Validating this accelerated adoption, according to Sofwave Medical, March 2025, in the 'Fourth Quarter and Full Year 2024 Financial Results', the company reported that pulse recurring revenue grew by 79% year-over-year to reach $23.3 million, underscoring the integration of these platforms into clinical practices.

Simultaneously, there is a growing clinical emphasis on synergistic combination therapies, pairing energy-based treatments with injectables or mechanical subcision to address the multifactorial nature of cellulite. This trend moves beyond single-modality approaches, allowing providers to customize protocols that simultaneously target fibrous septae and skin laxity for enhanced results. By integrating diverse mechanisms, clinics offer comprehensive body contouring solutions that deliver durable outcomes. Highlighting the commercial viability of this integrated model, according to Sisram Medical, March 2025, in the '2024 Annual Results', the company recorded a total annual revenue of $349.1 million, driven by a synergistic ecosystem combining devices and injectables to meet diverse consumer needs.

Segmental Insights

The Non-Invasive Treatment segment currently represents the fastest-growing category within the Global Cellulite Treatment Market. This expansion is primarily driven by a distinct shift in patient preference toward aesthetic procedures that require minimal recovery time and carry fewer risks than surgical alternatives. The growth is further supported by the increasing availability of energy-based devices that have received clearance from regulatory bodies such as the U.S. Food and Drug Administration. These clearances provide necessary safety validation, thereby encouraging wider adoption among individuals seeking effective cosmetic improvements without invasive medical intervention.

Regional Insights

North America maintains a leading position in the global cellulite treatment market, primarily driven by high disposable income and widespread acceptance of aesthetic procedures. The region benefits significantly from the presence of key industry players and a well-established healthcare infrastructure. A crucial factor supporting this dominance is the rigorous clearance process by the U.S. Food and Drug Administration, which ensures device safety and instills consumer confidence in available treatments. Furthermore, the growing patient preference for minimally invasive cosmetic interventions continues to support market expansion across the United States and Canada.

Recent Developments

• In December 2025, Galderma announced that it had received certification under the European Union Medical Device Regulation for its injectable poly-L-lactic acid treatment, Sculptra, for use on the body. This regulatory approval expanded the product's indications to include the improvement of cellulite appearance and skin laxity in the gluteal area and posterior thighs. The certification was supported by clinical data showing that the treatment stimulated the body's natural collagen production, leading to progressive improvements in skin quality and firmness. This development provided the Global Cellulite Treatment Market with a verified regenerative biostimulator option for holistic body contouring.
• In November 2024, Tiger Aesthetics Medical, LLC completed the acquisition of Revelle Aesthetics, Inc., the developer of the Avéli system. This strategic transaction significantly bolstered Tiger Aesthetics' position in the Global Cellulite Treatment Market by adding a targeted, FDA-cleared device for cellulite reduction to its portfolio. Avéli is a minimally invasive solution that allows practitioners to identify and precisely release the fibrous septa bands responsible for cellulite dimpling on the buttocks and thighs. The acquisition enabled the company to offer a more complete suite of regenerative body aesthetics products, addressing the significant unmet need for long-term cellulite treatment options.
• In May 2024, DELEO officially launched its Cellution device in the United Kingdom, introducing a new non-invasive technology to the Global Cellulite Treatment Market. The platform integrates four distinct technologies—high-intensity focused diodes, mechanical massage, active dermo-cosmetic ingredients, and radial vibration waves—to address the structural causes of cellulite and improve skin texture. The launch was marked by a demonstration event in London, highlighting the device's ability to offer comprehensive body contouring and lymphatic drainage. This expansion aimed to meet the rising consumer demand for effective, non-surgical treatments that reduce cellulite visibility without the downtime associated with invasive procedures.
• In January 2024, Cynosure and Lutronic announced that they had entered into a definitive merger agreement to effect a strategic combination of their global medical aesthetic device operations. Both companies are established leaders in energy-based systems, offering technologies utilized extensively within the Global Cellulite Treatment Market for body contouring and skin revitalization. This consolidation created a unified global entity with a highly diversified product portfolio and enhanced research and development capabilities. The merger was designed to strengthen their commercial presence across more than 130 countries, ensuring a reinforced supply chain and providing practitioners with a broader range of innovative aesthetic solutions for patients.

Key Market Players

• Hologic, Inc.
• Merz Pharma GmbH & Co. KGaA
• Syneron Medical Ltd
• Zimmer MedizinSysteme GmbH
• Alma Lasers Ltd
• Cymedics Holding S.R.O.
• Beijing Nubway S&T Co., Ltd.
• Candela Corporation
• Cutera Inc.
• Tanceuticals LLC

By Procedure Type	By Cellulite Type	By End-use	By Region
Non-invasive treatment Minimally invasive treatment Topical treatment	Soft cellulite Hard cellulite Edematous cellulite	Hospitals Clinics & beauty Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Cellulite Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Cellulite Treatment Market, By Procedure Type:

• Non-invasive treatment
• Minimally invasive treatment
• Topical treatment

• Cellulite Treatment Market, By Cellulite Type:

• Soft cellulite
• Hard cellulite
• Edematous cellulite

• Cellulite Treatment Market, By End-use:

• Hospitals
• Clinics & beauty Centers
• Others

• Cellulite Treatment Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE